Blog

Berit Rosenstiel Berit Rosenstiel

PFAS and the States

A recent meeting of the Environmental Protection Agency concerning its plan to rescind and reconsider the landmark drinking water standard on PFAS set under the Biden Administration saw complaints about the regulations from state officials and industry representatives.

Read More
Berit Rosenstiel Berit Rosenstiel

340B Rebate Program

The Trump Administration has announced a new pilot program for the 340B drug pricing program that would reduce discounts in favor of rebates.

Read More
Berit Rosenstiel Berit Rosenstiel

Delaware’s Food Desert Response

The Delaware Grocery Initiative, a program created to increase access to affordable healthy food in underserved communities, is moving forward with its first round of funding.

Read More
Berit Rosenstiel Berit Rosenstiel

Minnesota’s PFAS Problem

The number of wells flagged for elevated levels of PFAS chemicals in the Twin Cities was 30 times higher in 2024 than in the previous year, reflecting the increase of PFAS levels nationwide.

Read More
Berit Rosenstiel Berit Rosenstiel

Rural Healthcare Crisis in Texas

The recent closure of Mid Coast Medical Center in Trinity, Texas is indicative of a statewide pattern of rural hospitals closing and leaving patients behind.

Read More
Berit Rosenstiel Berit Rosenstiel

Rural Food Deserts

Food access should be plentiful in rural areas that produce their own food; however, food insecurity has become so pervasive in the United States that even rural communities are scrambling to find solutions to food deserts.

Read More
Berit Rosenstiel Berit Rosenstiel

340B faces potential new Oversight

Recent news from the Trump administration suggests that oversight of the 340B federal drug discount program could move to the Centers for Medicare and Medicaid Services (CMS).

Read More
Berit Rosenstiel Berit Rosenstiel

Flint’s Lead Failures

Eleven years after Flint, Michigan made headlines for the lead contamination in their water lines, their lead line replacement program is wrapping up, but at what cost?

Read More
Berit Rosenstiel Berit Rosenstiel

Employers Critique 340B

The 340B drug pricing program, which was designed to help hospitals and clinics treat a large population of low-income and uninsured patients with outpatient drugs, has faced widespread criticism in recent years.

Read More
Berit Rosenstiel Berit Rosenstiel

340B and Overprescription

A recent study reveals that breast cancer patients at practices participating in the 340B  program are 25% more likely to be prescribed outpatient drugs.

Read More
Berit Rosenstiel Berit Rosenstiel

Illinois’ Lead Problem

Lead in the water of 72 Illinois communities is reaching levels so high that officials are notifying cities and looking into ways to act.

Read More